Oestrogens prevent the increase of human serum soluble interleukin‐6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Interleukin‐6 (IL‐6) seems to be a key mediator of the increased bone loss that follows loss of ovarian function. Based on this and on evidence that oestrogen deficiency may also increase cell sensitivity to IL‐6, we studied the effects of ovariectomy and of oestrogen replacement therapy on the serum levels of IL‐6 and of soluble IL‐6 receptor (sIL‐6R) in vivo. DESIGN AND PATIENTS: Thirty‐seven fertile women undergoing surgery for benign uterine diseases were divided into 3 groups and monitored for 12 months: hysterectomized women (n = 9), ovariectomized untreated women (n = 12) and ovariectomized women starting treatment with transdermal estradiol (E 2, 50 μg/d) 1 month after surgery (n = 16). RESULTS: Hysterectomy alone caused no significant changes of sIL6R whereas serum levels of sIL‐6R rose progressively after ovariectomy (mean ± SEM: 31 ± 9% and 38 ± 7% over baseline, at 6 and 12 months, respectively; P < 0.01). Oestrogen replacement therapy prevented the increase of sIL6R over a 1‐year period. A similar pattern was also found for serum IL‐6 but the changes did not reach statistical significance. In ovariectomized (OVX) women there were significant correlations between serum sIL‐6R levels and FSH (r = 0.59; P < 0.01), oestradiol (r = − 0.43; P < 0.01), testosterone (r = − 0.41; P < 0.05), osteocalcin (r = 0.42; P < 0.05) and bone alkaline phosphatase (r = 0.44; P < 0.05). To examine whether oestrogen directly regulates sIL‐6R secretion by bone cells, we studied in vitro the basal and phorbol ester (PMA) stimulated release of sIL‐6R in a human osteoblastic cell‐line (MG‐63) and in a tumour‐derived osteoclastic cell line (GCT‐51). Osteoblastic (but not osteoclastic) cells spontaneously produced considerable amounts of sIL‐6R and the protein kinase‐C activator PMA (10−8 M) increased the release of sIL‐6R by osteoblasts more than 3‐fold. More strikingly, 17β E 2 (but not 17α) significantly inhibited both the spontaneous‐ and PMA‐induced release of sIL‐6R by osteoblastic cells (P < 0.05). CONCLUSIONS: These results indicate that oestrogen loss causes alterations of the IL‐6 system, and that sIL‐6R is under the direct inhibitory control of oestrogens both in vivo and in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathophysiologic Roles of Interleukin-6 in Human Disease
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-2-199801150-00009 · Cited by 1,146 · cited 1×
“Interleukin-6 (IL-6) has been implicated in the pathophysiology of osteoporosis caused by oestrogen de®ciency (Manolagas & Jilka, 1995; Papanicolaou et al., 1998).”
BackgroundEstrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
In Vitro Secretion of Cytokines by Human Bone Marrow: Effects of Age and Estrogen Status
Cheleuitte, D. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.2043 · Cited by 78
Cited by
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway
Maggio, M., Guralnik, J. M., Longo, D. L., & Ferrucci, L. (2006) · The Journals of Gerontology: Series A · doi:10.1093/gerona/61.6.575 · Cited by 692
McCarthy, M., & Raval, A. P. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01998-9 · Cited by 254
Giuliani, N., Sansoni, P., Girasole, G., Vescovini, R., Passeri, G., Passeri, M., & Pedrazzoni, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00220-5 · Cited by 151
Self-citation
Metadata
- Authors
- Girasole, G., Giuliani, N., Modena, A. B., Passeri, G., & Pedrazzoni, M.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1999-12
- Volume
- 51
- Issue
- 6
- Pages
- 801-807
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2060149005
- Cited by
- 46
- References
- 3
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oestrogens prevent the increase of human serum soluble interleukin‐6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. https://app.cochat.ai/papers/10.1046/j.1365-2265.1999.00896.x
- The paper
- Girasole, G., Giuliani, N., Modena, A. B., Passeri, G., & Pedrazzoni, M. (1999). Oestrogens prevent the increase of human serum soluble interleukin‐6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1999.00896.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.